Quest Pharmatech Stock Price Prediction

QPTFF Stock  USD 0.01  0.00  0.00%   
As of 13th of December 2024 the relative strength index (rsi) of Quest PharmaTech's share price is below 20 indicating that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of Quest PharmaTech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Quest PharmaTech and does not consider all of the tangible or intangible factors available from Quest PharmaTech's fundamental data. We analyze noise-free headlines and recent hype associated with Quest PharmaTech, which may create opportunities for some arbitrage if properly timed.
Using Quest PharmaTech hype-based prediction, you can estimate the value of Quest PharmaTech from the perspective of Quest PharmaTech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Quest PharmaTech to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Quest because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Quest PharmaTech after-hype prediction price

    
  USD 0.0133  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Quest PharmaTech Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Quest PharmaTech. Your research has to be compared to or analyzed against Quest PharmaTech's peers to derive any actionable benefits. When done correctly, Quest PharmaTech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Quest PharmaTech.

Quest PharmaTech After-Hype Price Prediction Density Analysis

As far as predicting the price of Quest PharmaTech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Quest PharmaTech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Quest PharmaTech, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Quest PharmaTech Estimiated After-Hype Price Volatility

In the context of predicting Quest PharmaTech's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Quest PharmaTech's historical news coverage. Quest PharmaTech's after-hype downside and upside margins for the prediction period are 0.01 and 0.01, respectively. We have considered Quest PharmaTech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.01
0.01
After-hype Price
0.01
Upside
Quest PharmaTech is very steady at this time. Analysis and calculation of next after-hype price of Quest PharmaTech is based on 3 months time horizon.

Quest PharmaTech Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Quest PharmaTech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quest PharmaTech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Quest PharmaTech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
15 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.01
0.01
0.00 
0.00  
Notes

Quest PharmaTech Hype Timeline

Quest PharmaTech is at this time traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Quest is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Quest PharmaTech is about 0.0%, with the expected price after the next announcement by competition of 0.01. About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.19. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Quest PharmaTech recorded a loss per share of 0.39. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be within a week.
Check out Quest PharmaTech Basic Forecasting Models to cross-verify your projections.

Quest PharmaTech Related Hype Analysis

Having access to credible news sources related to Quest PharmaTech's direct competition is more important than ever and may enhance your ability to predict Quest PharmaTech's future price movements. Getting to know how Quest PharmaTech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Quest PharmaTech may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
COYACoya Therapeutics, Common 0.18 10 per month 5.82  0.01  8.56 (7.20) 44.12 
CUECue Biopharma(0.21)9 per month 5.89  0.11  20.27 (11.51) 67.78 
LTRNLantern Pharma(0.12)9 per month 4.02 (0.01) 9.58 (6.59) 28.68 
FENCFennec Pharmaceuticals 0.35 9 per month 3.80  0.05  7.87 (6.68) 23.48 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.25) 6.00 (9.35) 22.16 
LIFEATyr Pharma 0.03 1 per month 2.62  0.07  6.45 (5.29) 28.98 
TRVITrevi Therapeutics(0.19)10 per month 3.67  0.03  6.59 (6.47) 17.04 
ANTXAN2 Therapeutics(0.02)10 per month 1.95  0.11  6.34 (4.52) 28.89 
BCABBioatla 0.02 10 per month 0.00 (0.05) 12.86 (7.59) 31.41 
BTTXBetter Therapeutics 0.00 0 per month 0.00 (0.14) 12.64 (9.62) 36.53 
PHGEBiomx Inc 0.02 3 per month 0.00 (0.12) 6.86 (6.49) 32.03 
FRTXFresh Tracks Therapeutics 0.00 0 per month 5.64  0.06  7.84 (11.11) 49.60 
CYCCCyclacel Pharmaceuticals(0.05)7 per month 0.00 (0.17) 12.87 (15.66) 48.10 
CINGCingulate 0.14 5 per month 0.00 (0.11) 7.19 (8.33) 38.00 
ASMBAssembly Biosciences(0.42)6 per month 0.00 (0.05) 8.79 (6.46) 21.34 
TILInstil Bio(1.12)6 per month 7.88  0.01  14.68 (10.89) 105.83 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.08) 4.05 (3.53) 27.84 
SPROSpero Therapeutics(0.01)9 per month 0.00 (0.15) 3.45 (4.58) 14.92 
CTMXCytomX Therapeutics 0.01 10 per month 0.00 (0.07) 6.78 (5.22) 22.92 
BCRXBioCryst Pharmaceuticals(0.34)10 per month 3.50 (0.03) 5.27 (4.34) 18.53 
KZRKezar Life Sciences(0.06)9 per month 2.62  0.05  4.93 (4.39) 51.13 
IMUXImmunic 0.01 9 per month 0.00 (0.1) 7.27 (6.84) 23.75 
ATRAAtara Biotherapeutics 0.12 8 per month 4.70  0.08  11.98 (7.52) 32.64 
PIRSPieris Pharmaceuticals(0.36)6 per month 0.00 (0.07) 3.23 (2.71) 10.25 

Quest PharmaTech Additional Predictive Modules

Most predictive techniques to examine Quest price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quest using various technical indicators. When you analyze Quest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Quest PharmaTech Predictive Indicators

The successful prediction of Quest PharmaTech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Quest PharmaTech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Quest PharmaTech based on analysis of Quest PharmaTech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Quest PharmaTech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Quest PharmaTech's related companies.

Story Coverage note for Quest PharmaTech

The number of cover stories for Quest PharmaTech depends on current market conditions and Quest PharmaTech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Quest PharmaTech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Quest PharmaTech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Quest PharmaTech Short Properties

Quest PharmaTech's future price predictability will typically decrease when Quest PharmaTech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Quest PharmaTech often depends not only on the future outlook of the potential Quest PharmaTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quest PharmaTech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding168.2 M

Complementary Tools for Quest Pink Sheet analysis

When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk